Efficacy of Topical Gentamicin in elective inguinal hernia surgery to prevent surgical site infection

Efficacy of Topical Gentamicin with single dose IV Ceftriaxone versus single dose IV Ceftriaxone in the prevention of Surgical Site Infection after open prosthetic inguinal hernia repair; A 1-year Randomized control trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092424

Enrollment

Registered

2025-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: Topical use of gentamicin: Topical use of gentamicin in elective inguinal hernia surgery Intervention2: Topical use of gentamicin in elective inguinal hernia surgery along with IV ceftr

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-60, ASA grade 1 to 2, unilateral hernia, reducible hernia, no comorbidities

Exclusion criteria

Exclusion criteria: acute kidney injury, chronic kidney disease, bilateral inguinal hernia, cardiac conditions,serum creatinine >1.3,irreducible hernia

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of Topical Gentamycin with single dose IV Ceftriaxone intraoperatively in patients undergoing elective Unilateral Lichtenstein inguinal hernia mesh repair in prevention of Surgical site infection.Timepoint: The outcome is checked on post op day-0, 3, 7, 10	—

Secondary

Measure	Time frame
InfectionTimepoint: 1 year	—

Countries

India

Contacts

Public ContactSagarika B

Jawaharlal nehru medical college

hombalp@yahoo.com6364506981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026